Dr Sadanandam’s team is working on a number of projects that they are keen to develop in collaboration with commercial partners.
Dr Paul Huang's Protein Networks team is keen to collaborate with industry partners on a number of projects on biochemistry, computational modelling, molecular pathology and proteomics.
Dr James Campbell, Lead Bioinformatican at the ICR, talks from the floor of the Festival of Genomics 2018 conference. He explains how he uses genomics approaches to improve radiotherapy treatments for prostate cancer.
Dr Marco Gerlinger's Translational Oncogenomics Team are keen to develop new partnerships to continue their work, and to access drugs that could reverse the resistance mechanisms that the team has identified so far.
ICR Researchers led by Dr Alessandro Vannini have captured images of molecular machinery called RNA Polymerase III in the act of transcribing a gene in exquisite and unprecedented detail.
Professor Uwe Oelfke, Deputy Head of the Division of Radiotherapy and Imaging, is keen to explore new opportunities for collaborative working with industry.
Our Molecular Addictions team, led by Dr Igor Vivanco, is working on a variety of projects that could be developed in collaboration with commercial partners.
In 2018, Professor Emma Hall will be seeking a PhD student to work in her team in the Division of Clinical Studies at the ICR.
Our scientists are pioneering research using high-tech equipment that could help solve the challenge of drug resistance.